Author:
Jani Ylber,Rexhepi Atila,Pocesta Bekim,Kamberi Ahmet,Ferati Fatmir,Xhunga Sotiraq,Serani Artur,Lala Dali,Zeqiri Agim,Mirto Arben
Publisher
Heighten Science Publications Corporation
Reference31 articles.
1. 1. Ford ES. Prevalence of the Metabolic Syndrome Defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005; 28: 2745-2749. Ref.: http://bit.ly/2FzEopG
2. 2. Ford ES, Li C, Zhao G. Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J Diabetes. 2010; 2: 180-193. Ref.: http://bit.ly/2ZUG3xN
3. 3. Pietro EL, Pier LC, Franco LP. Long QT Syndrome: An Emerging Role for Inflammation and Immunity. Front Cardiovasc Med. 2015; 2: 26. Ref.: http://bit.ly/2LmDBMF
4. 4. Evaristo FS, Alejandro TQ, Christian SP, Noemi GB, Cicero W, et al. Proinflamatory cytocines are soluble mediators linked with ventricular arrhythmias and contractile dysfunction in a rats model of metabolic syndrome. Oxid Med Cell Longev. 2017; 2017: 7682569. Ref.: http://bit.ly/2XE8DGc
5. 5. Watanabe H1, Tanabe N, Watanabe T, Darbar D, Roden DM, et al. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata Preventive Medicine Study. Circulation. 2008; 117: 1255-1260. Ref.: http://bit.ly/2Nh8hRW